会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • RETROVIRAL VECTORS FOR GENE TRANSFER INTO NEURONAL CELLS
    • 用于基因转移到神经细胞的转染载体
    • WO2003016539A1
    • 2003-02-27
    • PCT/US2002/007547
    • 2002-03-13
    • THOMAS JEFFERSON UNIVERSITY
    • DORNBURG, Ralph, C.SCHNELL, Matthias, J.DIETZSCHOLD, Bernhard
    • C12N15/85
    • C12N15/86C12N2740/13043C12N2740/13045C12N2810/60
    • The current methods of gene therapy do not allow for the efficient transduction of nerve cells, thereby limiting treatment of diseases or disorders involving the nervous system. The present invention is a method of treating a disease or disorder wherein an avian retrovirus (spleen necrosis virus, SNV) is engineered to express a rabies virus glycoprotein that allows for specific targeting of nerve cells. Since SNV is not infectious to human cells the retrovirus of the present invention is safe. Further, incorporation of a glycoprotein gene, specifically the N2C gene, and a therapeutic gene(s) of interest into the retroviral vector allows for the specific and efficient transduction of nerve cells with the gene(s) of interest, thereby treating a disease or disorder involving nerve cells.
    • 目前的基因治疗方法不能有效地转导神经细胞,从而限制了涉及神经系统的疾病或病症的治疗。 本发明是一种治疗疾病或病症的方法,其中将禽类逆转录病毒(脾坏死病毒,SNV)工程化以表达允许神经细胞特异性靶向的狂犬病病毒糖蛋白。 由于SNV对人体细胞不感染,所以本发明的逆转录病毒是安全的。 此外,将糖蛋白基因,特别是N2C基因和目的基因的治疗基因并入逆转录病毒载体中,允许具有目的基因的神经细胞的特异性和有效转导,从而治疗疾病或 涉及神经细胞的病症。